T1	Participants 86 107	diffuse lung disease.
T2	Participants 579 619	diffuse parenchymal lung disease (DPLD).
T3	Participants 668 741	95 patients who underwent fluoroscopy guided TBLB over a two year period.
T4	Participants 742 822	Patients with a lung mass or solitary lung nodule undergoing TBLB were excluded.
T5	Participants 1500 1518	patients with DPLD
T6	Participants 1535 1562	74 out of 95 patients (78%)
T7	Participants 1593 1677	Jumbo forcep while the smaller forcep was diagnostic in 62 out of 95 patients (65%).
T8	Participants 2080 2114	diffuse infiltrative lung disease.
